NAV2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.314600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.997400E-01
Normal-vs-Stage2
3.721200E-01
Normal-vs-Stage3
2.321400E-01
Normal-vs-Stage4
7.506800E-01
Stage1-vs-Stage2
1.797170E-01
Stage1-vs-Stage3
6.876000E-01
Stage1-vs-Stage4
5.873600E-02
Stage2-vs-Stage3
1.569250E-01
Stage2-vs-Stage4
6.469200E-01
Stage3-vs-Stage4
6.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.557600E-01
Normal-vs-AfricanAmerican
2.726400E-01
Normal-vs-Asian
3.070600E-01
Caucasian-vs-AfricanAmerican
4.178600E-01
Caucasian-vs-Asian
4.454600E-01
AfricanAmerican-vs-Asian
8.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.647200E-01
Normal-vs-Female
3.252800E-01
Male-vs-Female
5.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.156600E-01
Normal-vs-Age(41-60Yrs)
6.329600E-01
Normal-vs-Age(61-80Yrs)
2.484600E-01
Normal-vs-Age(81-100Yrs)
2.631600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.738960E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.151000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.942000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.534200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.534040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.338200E-01
Normal-vs-Daily Drinker
2.104400E-01
Normal-vs-Weekly Drinker
2.648600E-01
Normal-vs-Occasional Drinker
9.506600E-01
Normal-vs-Social Drinker
8.785400E-01
Non Drinker-vs-Daily Drinker
9.794000E-01
Non Drinker-vs-Weekly Drinker
9.853400E-01
Non Drinker-vs-Occasional Drinker
3.886000E-02
Non Drinker-vs-Social Drinker
1.711160E-01
Daily Drinker-vs-Weekly Drinker
9.971200E-01
Daily Drinker-vs-Occasional Drinker
4.054200E-02
Daily Drinker-vs-Social Drinker
1.890040E-01
Weekly Drinker-vs-Occasional Drinker
8.250500E-02
Weekly Drinker-vs-Social Drinker
2.084600E-01
Occasional Drinker-vs-Social Drinker
8.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.023420E-01
Normal-vs-Grade 2
3.683500E-02
Normal-vs-Grade 3
3.523600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.835710E-02
Grade 1-vs-Grade 3
6.078300E-03
Grade 1-vs-Grade 4
1.023420E-01
Grade 2-vs-Grade 3
3.488800E-01
Grade 2-vs-Grade 4
3.683500E-02
Grade 3-vs-Grade 4
3.523600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.614200E-01
Normal-vs-NonDiabetic
4.216200E-01
Diabetic-vs-NonDiabetic
4.766400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.820400E-01
Normal-vs-NoPancreatitis
2.622400E-01
Pancreatitis-vs-NoPancreatitis
1.239450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.013400E-01
Normal-vs-N1
3.190000E-01
N0-vs-N1
8.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.919600E-01
Normal-vs-TP53-NonMutant
4.416600E-01
TP53-Mutant-vs-TP53-NonMutant
1.78100999999042E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
